FDA Panel Endorses Booster Shot for J&J COVID-19 Vaccine

U.S. health advisers endorsed a booster of Johnson & Johnson’s COVID-19 vaccine, citing growing worry that Americans who got the single-dose shot aren’t as protected as those given two-dose brands.

  • Published
U.S. health advisers endorsed a booster of Johnson & Johnson’s COVID-19 vaccine Friday, citing growing worry that Americans who got the single-dose shot aren’t as protected as those given two-dose brands.
Image via AP Photo/Mark Lennihan, File

This article was republished here with permission from The Associated Press, however it is no longer available to read on Snopes.com.

WASHINGTON (AP) — U.S. health advisers endorsed a booster of Johnson & Johnson’s COVID-19 vaccine Friday, citing growing worry that Americans who got the single-dose shot aren’t as protected as those given two-dose brands.   Advisers to the Food and Drug Administration weighed J&J’s proposal for a flexible booster schedule. The company said the extra dose adds important protection as early as two months after initial vaccination — but that it might work better if…

Read at AP News